Header

UZH-Logo

Maintenance Infos

Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma


Eichelberg, Christian; Chun, Felix K; Bedke, Jens; Heuer, Roman; Adam, Meike; Moch, Holger; Terracciano, Luigi; Hinrichs, Kristin; Dahlem, Roland; Fisch, Margit; Schlomm, Thorsten; Sauter, Guido; Minner, Sarah (2013). Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma. International journal of cancer. Journal international du cancer, 132(12):2948-2955.

Abstract

Epithelial cell adhesion molecule (EPCAM) has recently attained a renewed interest as a candidate protein in diagnosis, prognostication and therapy of various tumor entities. The molecular epidemiology and prognostic relevance of EPCAM in renal cell carcinoma (RCC) and amongst the histological subtypes of RCC is unclear. We analyzed the prevalence and prognostic significance of EPCAM in a tumor tissue micro-array (TMA) composed of 1088 independent RCCs samples by immunohistochemistry (IHC). We found significant variations of EPCAM IHC staining intensities in between the RCC subtypes: In papillary and chromophobe RCC, the majority of tumors (89-93%) showed an at least weak EPCAM protein expression. In the largest subgroup, the clear cell (cc)RCC (n=767), a negative EPCAM IHC was found in 1/3 of the patients and was associated with high-grade disease and nodal metastases. Kaplan-Meier analyses demonstrated a significant association between positive EPCAM IHC and prolonged overall survival, even in a subset of low risk ccRCC. In multivariable analyses, EPCAM represented an independent risk factor of survival throughout all subgroups. For localized, low-grade ccRCC, information of EPCAM IHC raised predictive accuracy of a multivariate model by ∼5%, compared to T-stage and grade alone. Our findings indicate, that EPCAM is an independent prognostic molecular marker in ccRCC and, especially in localized ccRCC, might be able to provide auxiliary information for a better prognostication.

Abstract

Epithelial cell adhesion molecule (EPCAM) has recently attained a renewed interest as a candidate protein in diagnosis, prognostication and therapy of various tumor entities. The molecular epidemiology and prognostic relevance of EPCAM in renal cell carcinoma (RCC) and amongst the histological subtypes of RCC is unclear. We analyzed the prevalence and prognostic significance of EPCAM in a tumor tissue micro-array (TMA) composed of 1088 independent RCCs samples by immunohistochemistry (IHC). We found significant variations of EPCAM IHC staining intensities in between the RCC subtypes: In papillary and chromophobe RCC, the majority of tumors (89-93%) showed an at least weak EPCAM protein expression. In the largest subgroup, the clear cell (cc)RCC (n=767), a negative EPCAM IHC was found in 1/3 of the patients and was associated with high-grade disease and nodal metastases. Kaplan-Meier analyses demonstrated a significant association between positive EPCAM IHC and prolonged overall survival, even in a subset of low risk ccRCC. In multivariable analyses, EPCAM represented an independent risk factor of survival throughout all subgroups. For localized, low-grade ccRCC, information of EPCAM IHC raised predictive accuracy of a multivariate model by ∼5%, compared to T-stage and grade alone. Our findings indicate, that EPCAM is an independent prognostic molecular marker in ccRCC and, especially in localized ccRCC, might be able to provide auxiliary information for a better prognostication.

Statistics

Citations

11 citations in Web of Science®
11 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

254 downloads since deposited on 30 Nov 2012
52 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Pathology and Molecular Pathology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2013
Deposited On:30 Nov 2012 14:05
Last Modified:05 Apr 2016 16:08
Publisher:Wiley-Blackwell
Series Name:International journal of cancer. Journal international du cancer
ISSN:0020-7136
Publisher DOI:https://doi.org/10.1002/ijc.27970
PubMed ID:23180689

Download

Download PDF  'Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 1MB
View at publisher